Albany - New York, Sept. 27, 2016 -- In a new report, titled ‘Contraceptives Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,’ Transparency Market Research projects the market to expand at a steady 3.10% CAGR from 2014 to 2020. Factors such as the implementation of Affordable Care Act and the Patient Protection Act, the rising rate of unintended pregnancies, and the rising awareness programs by NGOs to promote the use of contraceptives are expected to propel the global contraceptives market. According to the report, the market is predicted to progress from US$15.7 bn in 2013 to US$19.6 bn by 2020.
Browse full Industry Research Report: http://www.transparencymarketresearch.com/contraceptives-market.html
Contraceptives, available in the form of drugs and devices, prevent sexually transmitted infections and unintentional pregnancy. Every year on 26th September, the World Contraception Day is celebrated by an alliance of 14 NGOs medical societies, and government organizations. This coalition is funded by Bayer Pharma AG. Such partnerships are predicted to spread awareness about reproductive health and sexually transmitted diseases among the masses.
The global contraceptives market is segmented on the basis of geography and product type. By geography, the global contraceptives market is divided into Asia Pacific, Europe, North America, and Rest of the World. In 2013, the global market was dominated by North America. Factors such as the high occurrence of unplanned pregnancies, favorable reimbursement policies, and the rising use of contraceptive pills are responsible for the dominance of the North America contraceptives market. Asia Pacific is projected to be the fastest-growing market for contraceptives owing to the growing use of contraceptive pills for pregnancy prevention.
By product type, the global contraceptives market is classified into drugs and devices. The analysts divide the drugs segment into oral contraceptive pills, topical contraceptives, and contraceptive injectable. The devices segment is sub-segmented into male contraceptive devices and female contraceptive devices. Low cost and ease of use make the female contraceptives the dominant segment in the global market. The growing number of unintended pregnancies, especially in rural areas, has propelled the demand for various contraceptives.
Get Research PDF for more Professional and Technical Insights: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344
Leading companies such as Actavis, Inc., Church & Dwight, Co., Inc., Mayer Laboratories, Inc., Reckitt Benckiser plc, Teva Pharmaceutical Industries Ltd., CooperSurgical, Inc., and The Female Health Company are expected to introduce new male contraceptive devices and female contraceptives in the global market to maintain their dominance. Mergers and acquisitions are also likely to help leading companies spread awareness of using contraceptives.
Going forward, factors such as the presence of many contraceptive pipeline products and the entry of new companies can be held responsible for the growth of the global contraceptives market. However, a few factors may restrict the growth of the market, predict the analysts. As per the findings of the research, side effects of contraceptives encourage people to try natural contraceptive methods. Moreover, the rising occurrence of infertility amongst women is restricting the use of contraceptives. Social and ethical issues are also expected to restrict the use of contraceptive products in the near future.
Browse Press Release on Contraceptives Market: http://www.transparencymarketresearch.com/pressrelease/contraceptives-market.htm
Key Segments of Global Contraceptives Market
Global Contraceptives Market, by Product Types
- Drugs
- Oral Contraceptive Pills
- Contraceptive Injectables
- Topical Contraceptives
- Devices
- Male Contraceptive Devices (Male Condoms)
- Female Contraceptive Devices
- Female Condoms
- Sub-dermal Contraceptive Implants
- Intrauterine Devices
- Contraceptive Vaginal Rings
- Contraceptive Diaphragm
- Contraceptive Sponges
- Non-Surgical Permanent Contraception Device
Global Contraceptives Market, by Geography
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)
Browse Other Research Reports:
- Reprocessed Medical Devices Market: http://www.transparencymarketresearch.com/reprocessed-medical-devices.html
- Preimplantation Genetic Diagnosis Market: http://www.transparencymarketresearch.com/asia-preimplantation-genetic-diagnosis-market.html
- Self-Care Medical Devices Market: http://www.transparencymarketresearch.com/self-care-medical-devices.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact Us: Rohit Bhisey Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
First Western Ship Transits Strait of Hormuz Since Iran War Began
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Britain Courts Anthropic Amid US Defense Department Dispute
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



